Interpace Biosciences Announces Record Third Quarter 2024 Financial and Business Results  ●Q3 Revenue of $12.3 million; a $3.2M and 35% increase year-over-year ●Q3 Test volume up 26% year over year to record levels ●Q3 Cash collections of $11.3M; a $1.4M and 15% increase...

Interpace Biosciences Announces Preliminary Full-year and Fourth Quarter 2023 Financial and Business Results  ●Q4 and FY Revenue of $10.3 million and $40.2 million; a $8.4 million and 26% increase year-over-year ●Q4 and FY Income from Continuing Operations of $0.8 million and $1.1 million; a $7.0 million and...